Michael Montano, MD
Orthopaedic Surgery · Wasilla, AKNPI 1912132614
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.3%), education and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Summit Surgical Corp. at 35.2% of the total. That places this record below the midpoint for orthopaedic surgery clinicians in AK, where the typical reported total is $3,204.
Across 51 payments — averaging $74.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Summit Surgical Corp.$1K
- Stryker$1K
- Arthrex$986
- Johnson & Johnson$226
- VB Spine LLC$80
- Avanos Medical$67
- plus $70 from 4 others
What the payments were for
- Travel & lodging$49413%
- Food & beverage$2,09855%
- Education$1,20032%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Summit Surgical Corp. | 2 | $1,336 |
| Stryker | 24 | $1,027 |
| Arthrex | 9 | $986 |
| Johnson & Johnson(2 entities) | 7 | $226 |
| VB Spine LLC | 1 | $80 |
| Avanos Medical | 4 | $67 |
| Pacira Therapeutics, Inc. | 1 | $21 |
| Heron Therapeutics, Inc. | 1 | $19 |
| Davol Inc. | 1 | $16 |
| Organogenesis Inc. | 1 | $14 |
How this compares
$3,792 in reported general payments places this provider in the 50th percentile of 63 orthopaedic surgery providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium ErDiclofenac Sodium | 35 | $1,439 |
| Meloxicam | 13 | $28 |
| Gabapentin | 11 | $27 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Wasilla
- Charles HaggertyWasilla$33K
- Garret SchuchartWasilla$8K
- Deryk AndersonWasilla$5K
- Gregory StrohmeyerWasilla$4K
- Richard StrohmeyerWasilla$115
- Bryan HaughomAnchorage$179K
- Benjamin PackardAnchorage$40K
- Kenneth ThomasAnchorage$35K
- Claudia ThomasJber$33K
- Neal EversonFairbanks$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.